Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fogpharma

Fogpharma
2015 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$66M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of cell-penetrating miniproteins (CPMPs) designed to target cancer-causing proteins inside cancer cells and neutralize them. The company's cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics. These CPMPs combine the target-engagement power of biologics with the cell-entry ability of small molecules and therefore have the potential to be a game-changing new-modality technology to the challenge of drugging refractory disease drivers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 100 Acorn Park Drive
  • 6th Floor
  • Cambridge, MA 02140
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fogpharma’s full profile, request a free trial.

Fogpharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 16-May-2018 $66M 0000 00000 Completed Product Development
1. Early Stage VC (Series A) 18-Aug-2017 0000 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Fogpharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Fogpharma Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA 00 000.00 0000000000 0 000.00
0000000 0000000000 Formerly VC-backed Watertown, MA 00 00000 000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000 0000000000 Formerly VC-backed Toronto, Canada 0 00.000 000000&0 00.000
0000 000000000000 Formerly VC-backed Geneva, Switzerland 000.00 000000&0 000.00
To view this company’s complete list of competitors, request access »

Fogpharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Blue Pool Capital Family Office Minority 000 0000 000000 0
GV Corporate Venture Capital Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
NFLS - Pivotal Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Fogpharma Executive Team (8)

Name Title Board
Seat
Contact
Info
Weiqing Zhou Co-Founder & Chief Operating Officer
Howard Stern Chief Scientific Officer
John McGee Ph.D Executive
David Lane Ph.D Co-Founder
Gerard Hilinski Ph.D Co-Founder & Senior Scientist
You’re viewing 5 of 8 executives. Get the full list »

Fogpharma Board Members (7)

Name Representing Role Since Contact
Info
Barbara Weber MD Self Board Member 000 0000
Edward Fitzgerald Fogpharma Board Member 000 0000
Gregory Verdine Ph.D Self Co-Founder, President, Chief Scientific Officer, Chief Executive Officer & Chairman 000 0000
Jeffrey Leerink SVB Leerink Board Member 000 0000
Krishna Yeshwant MD GV Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »